Safety of Estrogens in Lupus: Hormone Replacement Therapy
Status:
Terminated
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test
whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use
the hormone estrogen. In this part of the study, we will look at the effects of estrogen
replacement therapy on the activity and severity of disease in women with SLE.
Phase:
Phase 3
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Office of Research on Women's Health (ORWH)